|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00911 QIANHAI HEALTH
Nominal 
0.530 -0.010 (-1.852%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 116,760 | -65.745% | 677,121 | 519,699 | 961,291 | 1,961,704 |
| Cost of Sales | (109,048) | -66.621% | (653,523) | (490,029) | (996,894) | (1,885,222) |
| Gross Profit | 7,712 | -45.517% | 23,598 | 29,670 | (35,603) | 76,482 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 2,895 | -39.359% | 5,943 | 1,311 | (52,705) | (233,703) | |
| Taxation | (51) | -- | (2) | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,844 | -40.427% | 5,941 | 1,311 | (52,705) | (233,703) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 5 | 0.000% | (446) | (220) | (26) | (66) |
| Depreciation & Amortisation | 759 | -10.915% | 1,519 | 2,400 | 2,433 | 2,434 |
| Directors' Emoluments | -- | -- | -- | 1,678 | 1,335 | 2,649 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 1.680 | -40.426% | 3.510 | 0.770 | -31.100 | -137.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.226 | 0.025 | 0.005 | (0.031) |
| NBV per share ($) | 2.326 | -- | 2.309 | 2.275 | 2.267 | 2.577 |
| Remarks: | Real time quote last updated: 14/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 2,844 |
| %Change | -40.427% |
| EPS / (LPS) | HKD 0.017 |
| NBV Per Share ($) | HKD 2.326 |